Latest News and Press Releases
Want to stay updated on the latest news?
-
FSR convened more than 40 global clinicians and researchers in Chicago for inaugural sarcoidosis meetings.
-
FSR celebrates 25th anniversary in the fight against sarcoidosis with awards gala in Chicago.
-
aTyr Pharma Presents Additional Findings from Phase 3 EFZO-FIT™ Study in Late-Breaking Oral Abstract at the European Respiratory Society Congress 2025
-
Foundation for Sarcoidosis Research acknowledges results of aTyr Pharma’s Phase 3 trial of efzofitimod in pulmonary sarcoidosis.
-
aTyr Pharma Announces Topline Results from Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis
-
aTyr Pharma Announces Last Patient Visit in Phase 3 EFZO-FIT™ Study of Efzofitimod in Patients with Pulmonary Sarcoidosis
-
Podcast dedicated to rare disease sarcoidosis hits 100,000 downloads.
-
FSR Early Career Fellowship Grant is designed to support early-career investigators in sarcoidosis.
-
FSR Launches New and Improved Patient Registry
-
Mark Mallozzi, MD, MPH has been selected to receive the 2025 ATS/FSR Partner Grant.